中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Daxxify (daxibotulinumtoxinA-lanm)
    Daxxify (daxibotulinumtoxinA-lanm)
    departments：医美科
    drug：注射剂
    Active：daxibotulinumtoixnA-lanm
    indication：治疗与波纹肌和/或前宫肌活动相关的中度至重度大脑皱纹
    Licensor：Revance Therapeutics, Inc.
    Approved Country/Region：FDA
    Approval time：2022-09-07